Notification of Expiry of PABO Listed Options
Released
Released
Announcement PDF
ASX & Media Release
Notification of Expiry of PABO Listed Options
Melbourne, Australia; 3 July 2023: Patrys Limited (ASX: PAB, “Patrys” or the “Company”), a
therapeutic antibody development company, advises that the attached letter is being sent to
registered holders of the Company’s listed PABO options (ASX: PABO) (PABO Listed Options) advising
that the PABO Listed Options which are exercisable at $0.024 (2.4 cents) each, will expire at 5.00pm
(AEST) on Friday, 4 August 2023 (Expiry Date).
Officially quotation of the PABO Listed Options on ASX will cease at close of trading on Monday, 31
July 2023, being four business days before the Expiry Date.
The attached letter outlines some of the courses of action available to holders of these soon to expire
PABO Listed Options.
-Ends-
This announcement is authorised for release by the CEO of Patrys Limited on behalf of the Board
of Directors.
For further information, please contact:
General enquiries
James Campbell
Chief Executive Officer
P: +61 3 96703273
info@patrys.com
Media enquiries:
Haley Chartres
H^CK
P: +61 423 139 163
haley@hck.digital
Registered Office Address
Level 4, 100 Albert Road
South Melbourne VIC 3205
1
About Patrys Limited
Based in Melbourne, Australia, Patrys (ASX:PAB) is focused on the development of its deoxymab
platform of cell-penetrating antibodies as therapies for a range of different cancers. More information
can be found at www.patrys.com.
About Patrys’ deoxymab 3E10 platform: Patrys’ deoxymab platform is based on the deoxymab 3E10
antibody that was first identified as an autoantibody in a mouse model of the human disease systemic
lupus erythematosus (SLE). While most antibodies bind to cell surface markers, deoxymab 3E10
penetrates into the cell nuclei and binds directly to DNA where it inhibits DNA repair processes. Cancer
cells often have high levels of mutations and underlying deficiencies in the DNA repair mechanisms.
For these reasons, the additional inhibition of the DNA repair processes by deoxymab 3E10 can kill
cancer cells, but appears to have little impact on normal cells. As a single agent, deoxymab 3E10 has
been shown to significantly enhance the efficacy of both chemo- and radiotherapies. Further,
deoxymab 3E10 can be conjugated to nanoparticles to target delivery of chemotherapeutics and
imaging agents to tumours.
Patrys has developed two humanised forms of deoxymab 3E10, both which have improved activity
over the original deoxymab 3E10 antibody. PAT-DX1 is a dimer (two joined subunits) of the short chain
from the binding domain of deoxymab 3E10, while PAT-DX3 is a full-sized IgG antibody. In a range of
pre-clinical studies, PAT-DX1 has shown significant ability to kill cancer cells in cell models, human
tumour explants, xenograft and orthotopic models. PAT-DX1 has been shown to cross the blood brain
barrier, reduce tumour size, and increase survival in multiple animal models of brain cancer, other
cancers, and cancer metastases. PAT-DX1 is tumour-agnostic, meaning that it can target many
different tumour types in the body, regardless of specific tumour antigens. Patrys believes that PATDX1 may have application across a wide range of cancers including gliomas, melanomas, prostate,
breast, pancreatic and ovarian cancers.
Deoxymabs, such as PAT-DX1 and PAT-DX3, can be used to target nanoparticles carrying a payload of
anti-cancer drugs specifically to tumours. This allows specific delivery of cancer drugs to multiple types
of cancer while having minimal impact on normal, healthy cells.
Patrys’ rights to deoxymab 3E10 are part of a worldwide license to develop and commercialise a
portfolio of novel anti-DNA antibodies and antibody fragments, variants and conjugates discovered at
Yale University as anti-cancer and diagnostic agents. Six patents covering the unconjugated form of
deoxymab 3E10 (and derivatives thereof) have already been granted (Europe, Japan, China, and 3 in
the USA), and five patents covering nanoparticle conjugation have been granted (Australia, Canada,
China, India and the USA).
2
3 July 2023
Dear Option Holder,
EXPIRY OF PABO LISTED OPTIONS
We are writing to you as a registered holder of PABO listed options in Patrys Limited to remind you that the options
will expire at 5:00pm (AEST) on Friday, 4 August 2023.
Your option holding may be exercised in whole or in part by payment of $0.024 (2.4 cents) for each option by no
later than 5:00pm (AEST) on Friday, 4 August 2023. If payment is not received by 5:00pm (AEST) on Friday, 4 August
2023, the options will lapse and all rights under the options will cease at that time. On exercise, each PABO option
entitles the holder to receive one fully paid ordinary share in the Company.
Some of the courses of action available to you as a holder of these soon to expire options are:
a)
Exercise the options on or before 5:00pm (AEST) on Friday, 4 August 2023.
b)
Sell your options. Quotation of the options will cease at the close of trading on Monday, 31 July 2023.
c)
Do nothing (i.e. allow your options to expire). If you do not exercise or sell your options, they will expire at
5:00pm (AEST) on Friday, 4 August 2023 and your right to subscribe for ordinary shares in Patrys Limited at
$0.024 (2.4 cents) per share will lapse.
There is no obligation on option holders to exercise their options. However, under paragraph 5.2 of Appendix 6A of
the Australian Securities Exchange (ASX) Listing Rules, the Company is required to advise option holders of the
information contained in this notice.
The market sale price of ordinary shares in Patrys Limited on ASX was $0.01 (1 cent) on Friday, 30 June 2023, being
the last trading day prior to the date of this notice.
During the three (3) months preceding the date of this notice:
the highest market sale price of ordinary shares on ASX was $0.021 (2.1 cents) on 30 March 2023; and
the lowest market sale price of ordinary shares on ASX was $0.009 (0.9 cent) on 28 June 2023.
If you wish to exercise your options then you must complete the instructions set out on your “Options Exercise
Notice” form on the reverse of this notice. A payment of $0.024 (2.4 cents) per option exercised must be received
no later than 5:00pm (AEST) on Friday, 4 August 2023.
If you have any questions, please do not hesitate to contact the Company by email at info@patrys.com or by phone
on +61 3 9670 3273.
Yours faithfully,
Stefan Ross
Company Secretary
Patrys Limited
Patrys Limited | ASX:PAB
ACN: 123 055 363 | ABN: 97 123 055 363
Address: Level 4, 96-100 Albert Road, South Melbourne, VIC, 3205
T: +61 3 9670 3273
www.patrys.com
For all enquiries:
Phone:
the Company +61 3 9670 3273
*M000001Q02*
@ Email:
info@patrys.com
PAB
Make your payment:
MR SAM SAMPLE
123 SAMPLE STREET
SAMPLETOWN VIC 3000
See overleaf for details on how to make
your payment
Options Exercise Notice
Options exercisable at A$0.024 per Option expiring at 5:00pm (AEST) on Friday, 4 August 2023
This document can only be used in relation to the holding represented by the details printed overleaf. If you are in doubt how to deal with this
form, please contact your financial or other professional adviser.
Your option holding may be exercised in whole or in part by payment of $0.024 for each option by no later than 4 August 2023. Payment must
be received via BPAY or at the address overleaf by 5:00pm (AEST) on Friday, 4 August 2023. For every Option exercised, the Optionholder will
be issued one Ordinary Fully Paid Share in the capital of the Company. Options not exercised by 5:00pm (AEST) on Friday, 4 August 2023 will
lapse. If payment is made by BPAY you will be deemed to have submitted this Options Exercise Notice.
Please note that there is no obligation upon optionholders to exercise their Listed Options.
Step 1: Registration Details
Please check the details provided and update your address via
www.investorcentre.com if any of the details are incorrect.
If you have a CHESS sponsored holding, please contact your
Controlling Participant to notify a change of address.
Step 2: Make Your Payment
Your option holding may be exercised in whole or in part.
Enter the number of options you wish to exercise and the amount
of payment. By making your payment you confirm that you agree
to all of the terms and conditions of the Options expiring 4 August
2023.
By Mail: Complete the reverse side of the payment slip and detach
and return with your payment. Make your cheque, bank draft or
money order payable in Australian dollars to "Patrys Limited" and
cross "Not Negotiable". The cheque must be drawn from an
Australian bank. Cash is not accepted.
Payment will be processed on the day of receipt and as such,
sufficient cleared funds must be held in your account as cheques
received may not be re-presented and may result in your Options
Exercise Notice being rejected. Paperclip (do not staple) your
cheque(s) to the payment slip. Receipts will not be forwarded.
Funds cannot be debited directly from your account.
Entering your contact details is not compulsory, but will assist us if
we need to contact you.
Choose one of the following payment methods.
BPAY®: See overleaf. These BPAY details are unique to you. If you
are making payment via BPAY, you are not required to compete or
return the payment slip.
By submitting this Options Exercise Notice or by making payment by BPAY:
•
•
I/We request that you allot me/us the number of Ordinary Fully Paid Shares applied for and I/we agree to accept such shares
subject to the Constitution of the Company; and
I/We authorise you to register me/us as the holder(s) of the Ordinary Fully Paid Shares to be alloted and place my/our name on the
register
Turn over for details on how to make your payment
® Registered to BPAY Pty Limited ABN 69 079 137 518
916CR_0_Sample_CA/000001/000002/i
è
Options Exercise Notice
STEP 1
X 9999999991
For your security keep your SRN/
Registration Name & Offer Details
Registration Name:
Options Details:
I ND
HIN confidential.
MR SAM SAMPLE
123 SAMPLE STREET
SAMPLETOWN VIC 3000
Entitlement No: 12345678
Number of Options registered in your name as at
4 July 2023:
Number of Ordinary Fully Paid Shares to be issued on full exercise
Amount payable on full exercise of Options at $0.024 per Option:
STEP 2
Make Your Payment by 5:00pm (AEST) on Friday, 4 August 2023
To avoid postal delay make your payment via BPAY either online or by phone with your bank using the payment details below.
Cheque, bank draft or money order
BPAY
your cheque, bank draft or money order payable to
Make
"Patrys Limited" and cross "Not Negotiable".
Biller Code:
Ref No:
Contact your financial institution to make your
payment from your cheque or savings account.
Return your payment with the below payment slip to:
Computershare Investor Services Pty Limited
GPO BOX 52 Melbourne Victoria 3001 Australia
BPAY
Neither Computershare Investor Services Pty Limited (CIS) nor Patrys Limited accepts any responsibility for loss incurred through incorrectly completed BPAY
payments. It is the responsibility of the applicant to ensure that funds submitted through BPAY are received by this time. Eligible Optionholders should use the
customer reference number shown on this Application Form when making a BPAY payment.
MAIL
Neither CIS nor Patrys Limited accepts any responsibility if you lodge the payment slip below at any other address or by any other means.
Privacy Notice
The personal information you provide on this form is collected by CIS, as registrar for the securities issuers (the issuer), for the purpose of maintaining registers of
securityholders, facilitating distribution payments and other corporate actions and communications. In addition, the issuer may authorise us on their behalf to send
you marketing material or include such material in a corporate communication. You may elect not to receive marketing material by contacting CIS using the details
provided above or emailing privacy@computershare.com.au. We may be required to collect your personal information under the Corporations Act 2001 (Cth) and
ASX Settlement Operating Rules. We may disclose your personal information to our related bodies corporate and to other individuals or companies who assist us
in supplying our services or who perform functions on our behalf, to the issuer for whom we maintain securities registers or to third parties upon direction by the
issuer where related to the issuers administration of your securityholding, or as otherwise required or authorised by law. Some of these recipients may be located
outside Australia, including in the following countries: Canada, India, New Zealand, the Philippines, the United Kingdom and the United States of America. For
further details, including how to access and correct your personal information, and information on our privacy complaints handling procedure, please contact our
Privacy Officer at privacy@computershare.com.au or see our Privacy Policy at www.computershare.com/au/privacy-policies.
Detach here
Patrys Limited Acceptance Payment Details
*12345678*
Number of Options exercised:
Amount enclosed at $0.024 per
Option exercised:
A$
.
Entitlement No: 12345678
BPAY is the most efficient and secure form of payment. Your BPAY payment
details are shown above.
MR SAM SAMPLE
123 SAMPLE STREET
SAMPLETOWN VIC 3000
Contact & Cheque Details
Contact
Name
Drawer
Daytime
Telephone
Cheque Number
BSB Number
Account Number
Amount of Cheque
123456789123456789+0000000001-3051+14
Share your feedback
Discover